Black Diamond Therapeutics (BDTX)
(Delayed Data from NSDQ)
$3.75 USD
+0.09 (2.46%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $3.74 -0.01 (-0.27%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum B VGM
Black Diamond (BDTX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$14.83 | $20.00 | $9.00 | 305.19% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Black Diamond comes to $14.83. The forecasts range from a low of $9.00 to a high of $20.00. The average price target represents an increase of 305.19% from the last closing price of $3.66.
Analyst Price Targets (6 )
Broker Rating
Black Diamond currently has an average brokerage recommendation (ABR) of 1.14 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.14 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, six are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 85.71% and 14.29% of all recommendations. A month ago, Strong Buy made up 85.71%, while Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 6 |
Buy | 1 | 1 | 1 | 1 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.14 | 1.14 | 1.14 | 1.14 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/23/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
9/4/2024 | H.C. Wainwright & Co. | Robert Burns | Strong Buy | Strong Buy |
8/7/2024 | Wedbush Securities | Robert Driscoll | Strong Buy | Strong Buy |
7/31/2024 | Raymond James | Laura Prendergast | Moderate Buy | Moderate Buy |
7/17/2024 | Piper Sandler | Joseph M Catanzaro | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Marc Frahm | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.14 |
ABR (Last week) | 1.14 |
# of Recs in ABR | 7 |
Average Target Price | $14.83 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 73 of 252 |
Current Quarter EPS Est: | -0.35 |
BDTX FAQs
Black Diamond Therapeutics, Inc. (BDTX) currently has an average brokerage recommendation (ABR) of 1.14 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for Black Diamond Therapeutics, Inc. (BDTX) is $14.83. The current on short-term price targets is based on 7 reports.
The forecasts for Black Diamond Therapeutics, Inc. (BDTX) range from a low of $9 to a high of $20. The average price target represents a increase of $295.47 from the last closing price of $3.75.
The current UPSIDE for Black Diamond Therapeutics, Inc. (BDTX) is 295.47%
Based on short-term price targets offered by six analysts, the average price target for Black Diamond comes to $14.83. The forecasts range from a low of $9.00 to a high of $20.00. The average price target represents an increase of 305.19% from the last closing price of $3.66.